Differentiation between progression and pseudoprogresion by arterial spin labeling MRI in patients with glioblastoma

Marija Jovanovic1, Sandra Radenkovic, Tatjana Stosic-Opincal

  • 1Clinical Center of Serbia, Radiology and MRI Center, Belgrade, Serbia.

Abstract

Insights

Arterial spin labeling (ASL) is a reliable alternative to dynamic susceptibility contrast-enhanced (DSC) perfusion weighted-imaging (PWI) for evaluating glioblastoma multiforme (GBM) progression. ASL effectively distinguishes between tumor progression and pseudoprogression in GBM patients.

Area of Science:

  • Neuroimaging
  • Radiology
  • Oncology

Background:

  • Glioblastoma multiforme (GBM) requires accurate monitoring for treatment response and disease progression.
  • Dynamic susceptibility contrast-enhanced perfusion weighted-imaging (DSC-PWI) is the established method for assessing GBM perfusion.
  • Arterial spin labeling (ASL) is an emerging perfusion technique with potential advantages.

Purpose of the Study:

  • To compare the efficacy of ASL perfusion technique against the established DSC-PWI.
  • To evaluate the utility of ASL in the routine MRI assessment of disease progression in GBM patients.

Main Methods:

  • A prospective intraindividual study involving 31 GBM patients with clinical deterioration post-treatment.
  • Conventional brain MRI with both ASL and DSC techniques on a 3T unit.
  • Analysis of cerebral blood flow (CBF) and cerebral blood volume (CBV) maps using normalized regions of interest (ROIs).

Main Results:

  • A high linear correlation (r=0.733; p<0.001) was observed between ASL and DSC-PWI in tumor ROIs.
  • ASL CBF maps were informative in 92% of cases and detected all lesions identified by DSC MRI.
  • Both techniques yielded closely correlated perfusion values.

Conclusions:

  • ASL perfusion imaging is a reliable alternative to DSC-PWI for GBM evaluation.
  • ASL effectively differentiates between true GBM progression and pseudoprogression.
  • ASL can be integrated into routine MRI protocols for monitoring GBM patients.